Cancer Immunology
The Cancer Immunology Research Program at Winship Cancer Institute of Emory University conducts research aimed at preventing and treating cancer through harnessing the immune system.
Program Overview
The Cancer Immunology Research Program integrates and strengthens immuno-oncology efforts within Winship Cancer Institute of Emory University, bringing together faculty conducting basic, clinical and translational research in cancer immunology.
Focused on translating innovative concepts to the clinic, the program prioritizes addressing unmet patient needs. Its primary aims include identifying the cellular and molecular mechanisms regulating antitumor immunity and testing new immunologic approaches for cancer treatment and prevention.
Supported by Winship's Center for Cancer Immunology and the Emory Vaccine Center and multiple shared resources including Immune Monitoring and Cellular and Immunotherapy, the program accelerates the translation of new cancer cell therapies from the lab to clinical trials for patients.
Program members aim to understand the cellular and molecular mechanisms governing anti-tumor immunity and to develop and evaluate novel immunologic strategies for cancer treatment and prevention.
The program has made groundbreaking scientific contributions and is poised to continue driving advancements in the field of cancer immunology and immunotherapy.
I feel confident that Winship of Emory is the place for these discoveries and advancements to be made and to determine how to leverage these mechanisms to target the cells and direct them to do what we need them to do to turn on the immune response.
